Pharmacodynamic Effects of Different Ticagrelor Maintenance Dosing Regimens With and Without Aspirin in Patients With Diabetes Mellitus: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-7 Study
Latest Information Update: 11 Oct 2024
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Coronary artery disease; Thrombosis
- Focus Pharmacodynamics
- Acronyms OPTIMUS-7
- 07 Oct 2024 Status changed from active, no longer recruiting to completed.
- 03 Apr 2024 Status changed from recruiting to active, no longer recruiting.
- 07 Jun 2023 Planned End Date changed from 1 Aug 2023 to 1 Aug 2024.